Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Meaning-Centered Psychotherapy for Caregivers of Cancer Patients

Official title: Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers

Run by Icahn School of Medicine at Mount Sinai · NCT06307535 · Data updated 2026-11-12

This study is testing if a special type of therapy called Meaning-Centered Psychotherapy can help caregivers of cancer patients feel less stressed and find more meaning in their lives compared to regular support therapy.

More Caregiver Burden trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations8 sites (Miami, Florida and 7 other locations)
StatusRecruiting
StartedMarch 13, 2024
Main results expectedMarch 1, 2029
Study endsMarch 1, 2029
Registry record updatedMay 26, 2026
Trial IDNCT06307535 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are caregivers aged 18 or older who are currently caring for patients with advanced solid tumor cancer and experiencing distress related to their caregiving role.

Probably not a fit

Patients who are not currently caregivers or those engaged in regular individual psychotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Meaning-Centered Psychotherapy for caregivers of patients with Stage III or IV solid tumor cancer. Participants will complete questionnaires assessing their sense of meaning, spiritual well-being, and levels of distress before and after undergoing either Meaning-Centered Psychotherapy or standard Supportive Psychotherapy. The study aims to determine the impact of these interventions on caregiver burden and stress over a period of time. Participants will be monitored through follow-up questionnaires at 2 weeks, 6 months, and 12 months post-treatment.

Why it matters

Potential benefit: If successful, this study could significantly reduce caregiver burden and improve the mental well-being of caregivers for cancer patients.

How similar studies have gone: Other studies have shown promising results with psychotherapy approaches for caregivers, indicating potential success for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or over;
* As per self-report, a current caregiver to a patient with Stage III or IV solid tumor cancer currently receiving medical care of any kind (e.g., curative, palliative);
* Experiences distress as evidenced by a score of 4 or greater on the Distress Thermometer (DT) and an indication that this distress is associated with caregiving;
* As per self-report, can read and understand English;
* As per self-report, residing in New York, New Jersey, Connecticut, or Florida, or have the ability to complete sessions while complying with current telehealth regulations.

Exclusion Criteria:

* Participant does not have a reasonable understanding of the study activities by the judgment of the consenting professional;
* Engagement in regular individual psychotherapeutic support that the participant is unable or unwilling to put on hold for the course of treatment.

Where it's running

  • University of Miami (Data Collection AND Data Analysis)
    Miami, Florida, United States
    Recruiting
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth (Limited protocol activities)
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity)
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester (Consent only)
    Harrison, New York, United States
    Recruiting
Show 2 more locations
  • Memorial Sloan Kettering Cancer Center
    New York, New York, United States
    Recruiting
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites)
    Rockville Centre, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Allison Applebaum, PhD, FAPOS — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Allison Applebaum, PhD, FAPOS
  • Email: allison.applebaum@mssm.edu
  • Phone: 212-241-8561

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.